11:22 AM EST - The Yield Growth Corp. : Announced its subsidiary Flourish Mushroom Labs Inc. has completed an acquisition of approximately 18% of the outstanding shares of Translational Life Sciences Inc. ("TLS"). TLS is a biotechnology company focused on developing proprietary formulations that contain restricted substances such as psilocybin and cannabis to serve unmet medical needs in the market. This includes opioid dependence, psychotic illness, pain management and traumatic brain injuries such as concussions. The company also offers services to design and oversee clinical trials of restricted substances for third parties. The Yield Growth Corp.
shares BOSS:CNX are trading unchanged at $0.28.
